ArticleHuman vaccines & immunotherapeutics2025
Emerging insights into thyroid cancer from immunotherapy perspective: A correspondence.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in immunotherapy for thyroid malignancies: from molecular targets to clinical outcomes.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While recent studies, such as Wang et al. have explored immunotherapy trends in thyroid cancer, methodological limitations in data retrieval persist. To address this, we implemented a refined search strategy using the Web of Science Core Collection, targeting critical fields (title, abstract, author keywords) with enhanced terminology. This approach yielded 578 publications-41% more than prior studies (e.g. 409 in Wang et al.) - demonstrating the profound impact of search precision on bibliometric outcomes. Key findings revealed a surge in publications post-2017, global collaboration patterns, and high-impact research clusters. Our study uniquely integrates bibliometric analysis with machine learning to map the evolution of thyroid cancer immunotherapy, emphasizing predictive modeling of emerging therapies and clinical translation. We further provide an open-access analytics platform to streamline data reuse, enabling researchers to identify knowledge gaps and prioritize future investigations. By enhancing methodological rigor and fostering data-driven insights, this work accelerates the translation of immunotherapy advances into clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.